Terns Pharmaceuticals, Inc.
TERN
Ранг среди акций
#3573
Terns Pharmaceuticals, Inc. is a biopharmaceutical firm currently in the... Terns Pharmaceuticals, Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to advancing novel small-molecule treatments. Its primary focus lies in developing both standalone agents and combination therapies to address non-alcoholic steatohepatitis (NASH) and obesity. The company's pipeline includes several key drug candidates: TERN-101, a farnesoid X receptor agonist distinguished by its liver-specific distribution and non-bile acid properties, is presently undergoing Phase IIa clinical trials for NASH. TERN-201, a vascular adhesion protein-1 inhibitor, is in Phase Ib clinical studies, also targeting NASH. Terns is also progressing TERN-501, a thyroid hormone receptor beta agonist engineered for improved liver targeting and metabolic resilience, through Phase I clinical trials for NASH. Furthermore, the company is advancing TERN-601, an oral small-molecule Glucagon-Like Peptide-1 receptor agonist program, intended for the management of NASH and various metabolic conditions, including obesity. Established in 2016, Terns Pharmaceuticals maintains its corporate headquarters in Foster City, California.
Цена акции
$52.95
Последняя синхронизация: 2026-05-15
Рыночная капитализация
$4.77B
Изменение (1 день)
0.00%
Изменение (1 год)
514.27%
Страна
US
Торговля Terns Pharmaceuticals, Inc. (TERN)
Категория
Healthcare
История дроблений акций Terns Pharmaceuticals, Inc. (TERN)
Акции Terns Pharmaceuticals, Inc. (символ: TERN) прошли через 0 дроблений.
Последнее дробление произошло Oct 20, 2026.
Одна акция TERN, купленная до Oct 20, 2026, сейчас соответствует 0 акциям TERN.
Последнее дробление произошло Oct 20, 2026.
Одна акция TERN, купленная до Oct 20, 2026, сейчас соответствует 0 акциям TERN.
Список дроблений акций
| Год | Дробление | Коэффициент | Суммарный коэффициент |
|---|---|---|---|
| Недостаточно данных для указанных дат. | |||
Дробления акций аналогичных компаний или конкурентов
| Компания | Количество дроблений акций | Суммарный коэффициент | Страна |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|